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Sungkyunkwan University School of Medicine, Seoul, South KoreaObjectives. We report our 10 years experience of the surgical treatment of congenital arteriovenous malformation (AVM).
Methods. We retrospectively reviewed the medical records of 145 patients with AVM who visited Samsung Medical Center
in Korea from 1994 to 2003. Among the 145 patients, 21 patients were operated on. Preoperative embolo/sclerotherapy was
done in 20 out of the 21 patients.
Results. The surgically treated AVMs were 13 cases of head and neck lesions, four cases of upper extremity lesions, one case
each of back lesion, uterus lesion, lower extremity lesion and multiple site lesions. There were 10 patients with the
extratruncular infiltrating type, nine patients with the extratruncular limited type, one patient with a truncular superficial
AV fistula and one patient with a mixed type. Fourteen cases were operated on for cosmetic reasons and since they had
localized lesions, and five cases were operated on for tissue necrosis. Fourteen cases were cured by a single operation, yet
seven cases needed several sessions of operation to cure the AVM or to promote wound healing after surgery.
Conclusion. The surgical treatment of AVM is a challenging issue for vascular surgeons. To minimise the complications
related to surgery, a multidisciplinary team approach should be considered.Keywords: Congenital vascular malformation; Arteriovenous malformation; Sclerotherapy; Embolotherapy.Introduction
It has long been recognised that despite medical
advances congenital arteriovenous malformation
(AVM) is still a challenging subject among the many
vascular diseases. AVM displays various clinical
presentations and an unpredictable clinical course. It
can present with an asymptomatic lesion such as a
birth mark and a palpable mass; the symptoms can be
secondary to compression of the adjacent normal
structure or they can be complicated life threatening
conditions such as haemorrhage, high output heart
failure and ischemic necrosis due to the ‘steal’
phenomenon. The AVM may also remain dormant
and undetectable throughout the patient’s life. Gra-
dual enlargement of the AVM can occur in proportion
to the growth of the individual, while the haeman-
gioma usually regresses in late childhood.1 AVMing author. D.I. Kim, Division of Vascular
sung Medical Center, 50 Irwon-dong, Gangnam-gu,
, South Korea.
: dikim@smc.samsung.co.kr
0101 + 06 $35.00/0 q 2006 Elsevier Ltd. All rights resergrows in an expanding pattern due to the high blood
flow between the arteries and veins. AVM does not
show endothelial proliferation. Certain conditions
such as trauma, hormonal effects or incomplete
treatment of an AVM with a remnant nidus can result
in the explosive growth of the AVM. AVM can be
classified into the truncular lesion and the extratrun-
cular lesion according to Hamburg classification.2,3
The former lesion is embryonal dysplasia of differ-
entiated vascular trunk and involves central, axial
vessels. The latter lesion is derived from remnant of
primitive capillary network and involves peripheral
rather than mainstream vessels. The truncular lesion is
divided into superficial lesion and deep lesion. The
extratruncular lesion is divided into the infiltrating
lesion and the limited lesion. The infiltrating lesion has
diffuse involvement of arteriovenous shunting and is
rarely with venous defect. The limited lesion consists
of highly tortuous and ecstatic dysplastic vessels and
carvernous hollows with arteriovenous communi-
cations. Complete eradication of the nidus of an
AVM has been known to be the only option forEur J Vasc Endovasc Surg 32, 101–106 (2006)
doi:10.1016/j.ejvs.2006.01.004, available online at http://www.sciencedirect.com onved.
Table 1. Demographic data
Truncular type Extratruncular type Mixed
type
Superficial Deep Limited Infiltrating
Enrolled
AVM
2 2 36 98 7
Surgically
treated
AVM
1 0 9 10 1
J. Y. Kim et al.102a potential cure.4 Ablative surgery such as the Malan
operation was introduced for the complete removal of
AVM.5 Surgical treatment alone can result in massive
bleeding during the surgery and it can be life
threatening. With the recent progress of interventional
radiological techniques, a multidisciplinary approach
to AVM has been introduced and this has been
reported to be effective for the treatment of AVMs.6,7
The purpose of this study was to review the clinical
results of surgical treatment for AVMs, with or without
embolo/sclerotherapy, that were based on a multi-
disciplinary approach.Materials and Methods
Among the 1202 patients with congenital vascular
malformations (CVMs) who were investigated at
Samsung Medical Center, Seoul, Korea, from 1994 to
2003, there was one patient with arterial malfor-
mations (0.1%), 453 patients with venous malfor-
mations (37.7%), 145 patients with AVMs (12.1%),
393 patients with lymphatic malformations (32.7%)
and 102 patients with unclassified CVMs (8.5%).
Among 145 patients of AVMs, there were 59 male
patients and 86 female patients. The mean age was 28.7
years (age range: 2–67 years). The patients with AVM
were classified according to the Hamburg Classifi-
cation.2,3 There were four cases of truncular AVMs, 134
cases of extratruncular AVMs and seven case of the
mixed type AVM. Among the extratruncular AVMs,Table 2. Symptoms and signs of surgically treated arteriovenous
malformation
Symptoms and signs n(%)
Cosmetic problems 18 (85.7)
Thrill and pulsation 15 (71.4)
Sensation of heat 13 (61.9)
Port-wine stain 6 (28.6)
Pain 5 (23.8)
Tissue necrosis 5 (23.8)
Limb length discrepancy* 3 (14.3)
Bleeding 1 (4.8)
Cardiomegaly 1 (4.8)
* Limb length discrepancy: more than 1 cm difference.
Eur J Vasc Endovasc Surg Vol 32, July 2006there were 98 cases of infiltrating AVMs and 36 cases of
limited AVMs (Table 1).
We used various non-invasive and invasive tests for
the diagnosis of AVM. Non-invasive tests such as
duplex ultrasound imaging, computed tomography,
MRI with gadolinium contrast, transarterial lung
perfusion scan (TLPS), and whole body blood pool
scan (WBBPS) were first used for diagnosis, and then
selective catheter contrast angiography was done for
the more precise diagnosis and creating a therapeutic
plan.8 When the AVM was diagnosed, further review
was done and the treatment plan was made by the
multidisciplinary team.7,9,10
To minimise the morbidity related to surgery such
as massive bleeding, embolo/sclerotherapy was con-
sidered preoperatively. Absolute to 80% alcohol,
N-butyl cyanoacrylate (NBCA), various types of coils
and/or contour particles such as ivalon were used as
embolo/scleroagents in various combinations, simul-
taneously or in stages, and the final decisions
depended upon the location, severity and extent of
the AVM. The treatment response, as well as the
interim or final results, were periodically assessed by
the multidisciplinary team.Results
The 90 AVMs treated were among the total of 145 AVMs.
Fifty-five AVMs had no indication for treatment so they
have been followed up regularly. Seventy-nine
AVMs were treated solely by selective catheter
contrast angiography with embolisation/sclerotherapy
while 21 AVMs were treated with endovascular therapy
plus surgical excision. Twenty-one patients who under-
went surgical treatment showed various signs and
symptoms such as cosmetic problems, thrill and
pulsation, a sensation of heat, port wine stain, pain,
tissue necrosis, limb length discrepancy (more thanTable 3. Lesions and classifications of arteriovenous malformation
Lesions n(%) Extratruncular type Truncular
type
(superficial)
Mixed
type
Limited Infiltrating
Head
and neck
13(61.9) 7 4 1 1
Upper
extremity
4(19.0) 2 2
Back 1(4.8) 1
Uterus 1(4.8) 1
Lower
extremity
1(4.8) 1
Multiple 1(4.8) 1
Table 5. Frequency and type of operation
Fre-
quency
n(%) Type (number) Site (patients)
1 14(66.7) Excision (12) Head and neck (9)
Upper extremity (1)
Back (1)
Multiple (1)
Amputaion (1) Upper extremity (1)
Hysterectomy (1) Uterus (1)
2 3(14.3) Excision (1) Head and neck (1)
Amputation (2) Upper extremity (1)
Lower extremity (1)
3 2(9.5) Excision (1) Head and neck (1)
Excision and skin
graft (1)
Head and neck (1)
4 2(9.5) Excision and ear
reconstruction (1)
Head and neck (1)
Debridement and
ampuation (1)
Upper extremity (1)
Table 4. Indication for surgery
Indications n(%)
Cosmetic and localized lesion 14(66.7)
Tissue necrosis 5(23.8)
Bleeding 1(4.8)
Pain 1(4.8)
Fig. 1. Extratruncular limited type of arteriovenous malformati
Angiographic finding before embolosclerotherpy. (D) Angiogra
surgical excision.
Surgery for Congenital AVM 1031 cm), bleeding and cardiomegaly, and these are
summarised in Table 2.
The surgically treated AVMs were 13 cases of head
and neck lesions, four cases of upper extremity lesions
and one case each of back lesion, uterus lesion, lower
extremity lesion and lesions at multiple sites (Table 3).
There were 10 patients with the extratruncular
infiltrating type, nine patients with the extratruncular
limited type, one patient with truncular superficial
type and one patient with the mixed type (Table 3).
The cosmetic and localised lesions were the most
common indications for surgery and tissue necrosis
was the next most common indication (Table 4).
Of the 21 surgically treated patients, 20 patients had
multiple sessions of preoperative embolo/sclerother-
apy to facilitate the subsequent surgical excision.
Fourteen cases were cured with one operation though
seven cases needed several operations to cure the AVM
or to promote wound healing after the initial surgery
(Table 5).
We demonstrate four cases of surgical treatment in
Figs. 1–4. There was no lesion recurrence after surgery
during the follow-up period (meanZ22.1 months).on. (A) and (B) Gross and MRI findings before treatment. (C)
phic finding after embolosclerotherpy. (E) Gross finding after
Eur J Vasc Endovasc Surg Vol 32, July 2006
Fig. 2. Extratruncular limited type of arteriovenous malformation. (A) and (B) Gross and angiographic finding before
treatment. (C) Gross finding with necrosis of ear after embolosclerotherapy. (D) Gross finding after reconstruction of necrotic
ear.
J. Y. Kim et al.104Discussion
AVM has been a challenging disease for both the
doctors and the patients. It can be asymptomatic,
but it can create many problems such as cosmetic
disfigurement, pain, tissue necrosis, bleeding, limb
length discrepancy, heart failure and even psychia-
tric problems. Although advanced diagnostic tech-
niques now give us more information about AVM
than before, the treatment of AVM has been still
limited. It is usually not a life threatening condition
and the physician does not want to face the
possibility of serious complications during treatment
that can be life threatening. Treatment of AVM has a
high recurrence rate and incomplete treatment of
AVM can make the lesions larger than before
treatment in a short period of time.Eur J Vasc Endovasc Surg Vol 32, July 2006Some investigators11 have suggested six different
therapeutic tactics and surgical techniques that have
been proven as effective for the treatment of vascular
malformations. These are: (1) reconstructive surgery,
(2) surgery to reduce the haemodynamic activity of the
vascular defect, (3) surgery to extirpate the malformed
vessels, (4) combined therapy, (5) unconventional
therapy, and (6) the multidisciplinary approach to
treatment.
Surgical treatment alone can cause massive bleeding
during the operation. Most surgeons recommend
preoperative embolo/sclerotherapy.12 Surgeons
should consider several important points during the
surgical treatment of AVM. The first is that the nidus of
AVM should be completely removed for achieving a
complete cure of AVM. The remnant AVM may grow
and get bigger than before treatment within a short
Fig. 4. Extratruncular infiltrating type of arteriovenous malformation. (A) Gross finding of 4th toe gangrene. (B)
Angiographic finding. (C) MRI finding showed arteriovenous malformation in soft tissue and bone. (D) Gross finding after
below knee amputation.
Fig. 3. Extratruncular infiltrating type of arteriovenous malformation. (A) and (D) Gross and MRI findings before treatment.
(B) Tissue volume expander was inserted into the subcutaneous layer. (C) and (E) Gross and MRI findings after surgical
excision.
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J. Y. Kim et al.106period of time. Ligation of the feeding artery without
removal of nidus should be avoided. In this case, other
collateral vessels and quiescent AVMs will grow fast
and the AVM may get bigger than before. If the feeding
artery of the AVM is ligated, further embolo/scler-
otherapy was impossible because there will be no
accessible route for embolo/sclerotherapy.13
The postoperative complications were more com-
mon for the AVMs of the extratruncular infiltrating
type than for AVMs of the extratruncular limited type.
The patients with extratruncular infiltrating AVMs
had more diffuse lesions and these required more
embolo/sclerotherapy for surgery. Among the 10
patients with the infiltrating type, five patients (50%)
were operated on more than two times because of their
non-healing surgical wounds. However, only two
(20%) out of the nine patients with the limited type
underwent more than two operations.
All AVMs do not need to be treated if they do not
cause serious problems. If the AVM itself causes
problems like cosmetic problems, compression to
adjacent structure or complications like the ‘steal’
phenomenon, bleeding or heart failure, then treatment
of the AVM should be considered. The AVM is
generally not a life threatening disease, but the
massive bleeding or wide tissue necrosis related to
surgery and/or embolo/sclerotherapy might be life
threatening.
In conclusion, surgical treatment of AVM is a
challenging issue for vascular surgeons. To minimise
the complications related with surgery, a multidisci-
plinary team approach should be considered.Eur J Vasc Endovasc Surg Vol 32, July 2006References
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